AU2001246846A1 - Immunoassay of anti-hm1.24 antibody - Google Patents

Immunoassay of anti-hm1.24 antibody

Info

Publication number
AU2001246846A1
AU2001246846A1 AU2001246846A AU4684601A AU2001246846A1 AU 2001246846 A1 AU2001246846 A1 AU 2001246846A1 AU 2001246846 A AU2001246846 A AU 2001246846A AU 4684601 A AU4684601 A AU 4684601A AU 2001246846 A1 AU2001246846 A1 AU 2001246846A1
Authority
AU
Australia
Prior art keywords
immunoassay
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001246846A
Inventor
Yuji Ishikawa
Yasuko Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2001246846A1 publication Critical patent/AU2001246846A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
AU2001246846A 2000-04-06 2001-04-05 Immunoassay of anti-hm1.24 antibody Abandoned AU2001246846A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-105423 2000-04-06
JP2000105423 2000-04-06
PCT/JP2001/002964 WO2001077362A1 (en) 2000-04-06 2001-04-05 Immunoassay of anti-hm1.24 antibody

Publications (1)

Publication Number Publication Date
AU2001246846A1 true AU2001246846A1 (en) 2001-10-23

Family

ID=18618782

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001246846A Abandoned AU2001246846A1 (en) 2000-04-06 2001-04-05 Immunoassay of anti-hm1.24 antibody

Country Status (2)

Country Link
AU (1) AU2001246846A1 (en)
WO (1) WO2001077362A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652839B2 (en) 2002-10-30 2014-02-18 Chugai Seiyaku Kabushiki Kaisha HM1.24—utilizing cancer vaccines
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
WO2008033517A2 (en) 2006-09-13 2008-03-20 Abbott Laboratories Cell culture improvements
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN108295242B (en) * 2016-06-28 2021-06-18 深圳宾德生物技术有限公司 Pharmaceutical composition for preventing and/or treating psoriasis and application of CD317 extracellular domain protein
CN112462071B (en) * 2020-11-13 2023-02-07 北京元恩生物技术有限公司 Special enzyme-linked immunoassay kit for ribavirin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW474991B (en) * 1993-10-15 2002-02-01 Toshio Hirano Membrane protein polypeptide having function of pre-B cell proliferation and the encoded gene thereof
UA76934C2 (en) * 1996-10-04 2006-10-16 Chugai Pharmaceutical Co Ltd Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
JP3992298B2 (en) * 1997-10-03 2007-10-17 中外製薬株式会社 Natural humanized antibody
ATE462975T1 (en) * 1998-02-25 2010-04-15 Chugai Pharmaceutical Co Ltd METHOD FOR IMMUNOCHEMICAL TESTING OF ANTI-HM1.24 ANTIBODY

Also Published As

Publication number Publication date
WO2001077362A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2001246846A1 (en) Immunoassay of anti-hm1.24 antibody
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU2002210918A1 (en) Degraded agonist antibody
AU1290001A (en) Antibodies
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2001234125A1 (en) Antibody library
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
GB9809839D0 (en) Antibody
AU2001240819A1 (en) Proteomics database
AU2002222112A1 (en) Hybrid antibodies
AU2002210917A1 (en) Degraded TPO agonist antibody
AU4935000A (en) Antibodies
AU1687500A (en) Antihuman vegf monoclonal antibody
AU2002365649A1 (en) Anti-dota antibody
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
AU2001246934A1 (en) Agonist antibodies
AU2759899A (en) Purified sperm surface antigen, monoclonal antibody therefor and application therefor
AU2002221132A1 (en) Novel antibody
AU2452301A (en) Protein methylarginine-specific antibodies
AU2001267922A1 (en) Method of assaying the function of fc fragment of antibody
AU2001284899A1 (en) Methods and universal monoclonal antibody array
GB9828700D0 (en) Antibody
AU2001245781A1 (en) Cd18-binding antibodies inhibit stenosis-related disorders
AU2001295042A1 (en) Anti-stilbene antibodies